← All stories
Health, Longevity & Biohacking

Lieberman warns GLP-1 weight-loss drugs can drive significant muscle loss

By Egleze Editorial Desk · Published August 16, 2026 · Modern Wisdom · Harvard Professor: “I Tried Every Diet. This Is By Far The Worst.” - Daniel Lieberman
Lieberman warns GLP-1 weight-loss drugs can drive significant muscle loss
Modern Wisdom
Modern Wisdom
Harvard Professor: “I Tried Every Diet. This Is By Far The Worst.” - Daniel Lieberman

What was said

"One of the big concerns about about GOP ones is that people not only lose fat, they also lose muscle and they and they seem to lose a lot of muscle. It's a bit like beriatric surgery too."

Lieberman says GLP-1 drugs are “game changers” for weight loss but warns they may also cause substantial lean-mass loss, raising later frailty risk, particularly as patients age. He says he and colleagues published on the issue in JAMA, and advises strength training for people using the medications to help preserve muscle.

Verification status

Attributed speaker claim

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Source and context

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Programme
Modern Wisdom
Episode
Harvard Professor: “I Tried Every Diet. This Is By Far The Worst.” - Daniel Lieberman
Clip time
1:54:25
Original source
Watch the source segment →
From this episode
Modern Wisdom
Modern Wisdom

Harvard Professor: “I Tried Every Diet. This Is By Far The Worst.” - Daniel Lieberman

August 15, 2026 · 2h 8m · 6 Egleze moments
Read episode summary and key points →

More moments from this episode

Health, Longevity & BiohackingLieberman says Spain’s PREDIMED trial ended early over Mediterranean-diet benefits→Health, Longevity & BiohackingLieberman says Blue Zones longevity data rely on weak age records→ScienceLieberman says calorie-restriction longevity evidence ‘not even’ shown in primates→Health, Longevity & BiohackingLieberman says many GLP-1 users stop within two years→
More stories More from Modern Wisdom